CytoReason vs Kolgene
CytoReason vs Kolgene, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Kolgene on 15/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 15/100
- domain rating: 40/100 against 2/100
- headcount: 116 against 2
- LinkedIn following: 12,830 against 317
Kolgene
- headcount growth: +17.2% against +13.7%
At a glance
| Measure | CytoReason | Kolgene |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | Platform for managing genetic test send-out operations for medical professionals. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Genomics, HealthTech, MedTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2016 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CytoReason | Kolgene |
|---|---|---|
| Employees | 116 | 2 |
| Headcount growthLast 12 months | +13.7% | +17.2% |
| Total funding | $128M | Not published |
| Latest round | Series B | Bootstrapped |
| LinkedIn followers | 12,830 | 317 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Kolgene |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 15/100 |
| Traction | 60/100 | 5/100 |
| Team | 70/100 | Not published |
| Search visibility | 30/100 | 22/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 2/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Kolgene |
|---|---|---|
| Analytics | Segment | Not detected |
CytoReason vs Kolgene: common questions
Which is better, CytoReason or Kolgene?
On our 0-100 score CytoReason rates higher (68/100 against 15/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do CytoReason and Kolgene compare on the numbers?
CytoReason leads on our overall score (68/100 against 15/100), domain rating (40/100 against 2/100), headcount (116 against 2), LinkedIn following (12,830 against 317). Kolgene leads on headcount growth (+17.2% against +13.7%).
Read the full CytoReason review and pricing or the Kolgene review and pricing. You can also browse other CytoReason alternatives we track.